Estimating frailty and physical reserve from a quick photo gives oncologists a cheap, consistent read on who can handle aggressive treatment. Training on tens of millions of images and holding steady across lighting, pose and makeup shows this is serious science. Paired with clinical judgment, facial biomarkers can make cancer care more personalized and more accessible.
This is a promising proof of concept, but the hype is running far ahead of the evidence, since a risk ranking from a face photo hasn’t been validated as an individual survival estimate or as a guide to treatment decisions. Doctors already assess frailty at the bedside, and the study never tested whether the score adds anything beyond that judgment. Loose talk about predicting survival is closer to marketing than medicine.
© 2026 Improve the News Foundation.
All rights reserved.
Version 7.18.0